Layoffs, Restructuring at GSK
Tracy Vence | Dec 4, 2014
GlaxoSmithKline is eliminating 900 US jobs—most in R&D.
Ebola Vaccine Candidate Shows Promise
Molly Sharlach | Dec 1, 2014
An experimental Ebola vaccine developed by the US National Institutes of Health appears to be safe and effective, according to a small, early-stage clinical trial.
Novartis and Glaxo Agree to Big Deal
Bob Grant | Apr 22, 2014
The pharmaceutical companies announce a suite of asset swaps that drove up share prices and will reshape both.
Scandalous GSK Paper Retracted
Bob Grant | Dec 10, 2013
The publication at the center of a June controversy for drugmaker GlaxoSmithKline is finally pulled from the literature.
Top GSK Scientist Fired Over Paper
Bob Grant | Jun 19, 2013
The head of GlaxoSmithKline’s Shanghai neurodegenerative-disease research unit is axed after irregularities are uncovered in a 2010 paper he published.